Clinical Trial Update: Lung Cancer Mutation Consortium Protocol

View source ↗

Summary

A completed update on the Lung Cancer Mutation Consortium protocol, describing its study design and the condition of interest (adenocarcinoma of the lung, stage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Lung

Snippet

Sponsor: University of Colorado, Denver | Conditions: Adenocarcinoma of Lung, Stage IV | Status: COMPLETED